When building a strong brand identity, your logo is the star of the show. It’s often the first thing customers see, recognize ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

And it’s not like I’ve owned only Yamahas, either. I’ve had lots of other bikes, too—KTMs, a Triumph, Kawasakis, and even a ...

Copyright 2025 The Associated Press. All Rights Reserved. Leverkusen’s head coach Xabi Alonso looks on ahead of the German Bundesliga soccer match between Borussia ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...

Jury Rules Bayer (Monsanto) Must Pay $100M in Trial Over PCBs in Washington School. Bayer has been ordered to pay $100 million to four individuals who claim they suffered health issues due to exposure ...

Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid generic competition, wrote Connor Hart for the Wall ...

Bayer argues PCB levels were safe, blames school for ignoring warnings Previous trials resulted in over $1.5 billion in verdicts Jan 14 (Reuters) - A Washington jury on Tuesday ordered Bayer ...

The Puma logo has been made more concise and more accessible over time. Its current form is smooth and contemporary, representing its namesake's swiftness and lightness. Maybe Reebok’s vector logo ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...